SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations

By

Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations Matthew Mold,1 Emma Shardlow,1 and Christopher Exleya,1 Author information ► Article notes ► Copyright and License information ► Abstract Aluminium adjuvants remain the most widely used and effective adjuvants in vaccination and immunotherapy. Herein, the particle size distribution (PSD) […]

[Continue reading...]

Vaccination’s Dilemma: Unsafe at Any Dose

By Leave a Comment

Dilemma By Richard Gale and Gary Null Progressive Radio Network, May 3, 2016 The CDC and advocates for mandatory vaccination consistently repeat a dangerous mantra that finds no warranted basis in medical science.  This monolithic industry, now a massive network of private and government institutions, state senates, and supported by a compliant media, want us to […]

[Continue reading...]

CMSRI: On Vaccines, Adjuvants and Autoimmunity

By 2 Comments

By Celeste McGovern Immunologists survey the research and it’s not reassuring Add one more item to the growing stack of published medical literature linking vaccines to the current explosion of autoimmune diseases from skin afflictions to neurological disorders. A paper published online this month in the journal Pharmacological Research is an international team of immunologists’ […]

[Continue reading...]

HPV vaccination syndrome: A questionnaire-based study

By

Authors: Manuel Martínez-Lavín, Laura-Aline Martínez-Martínez, Paola Reyes-Loyola Abstract Isolated cases and small series have described the development of complex regional pain syndrome, postural orthostatic tachycardia, and fibromyalgia after human papillomavirus (HPV) vaccination. These illnesses are difficult to diagnose and have overlapping clinical features. Small fiber neuropathy and dysautonomia may play a major role in the pathogenesis of these entities. We […]

[Continue reading...]

Reduction in HPV Prevalence— No Evidence to Support HPV Vaccination reduces HPV Prevalence

By

Authors:  Jennifer A. Groner1, George D. Harris2 and Diane M. Harper3,4,5  TO THE EDITOR—The recent Centers for Disease Control and Prevention (CDC) study by Markowitz et al [1] provides limited and inconclusive data on 111 sexually active females between 14 and 19 years of age who received at least 1 dose of quadrivalent human papillomavirus vaccine (HPV4). The […]

[Continue reading...]

The New Gardasil: Is it right for your daughter?

By Leave a Comment

By Kelly Brogan, MD The New Gardasil I believe in living life with no regrets. When we make decisions from a place of authenticity, when we listen to our inner compass for guidance, check our fear, then we have done the best that we could have done. If it ends up being a mistake, then […]

[Continue reading...]

Cervarix: An M-cell-specific targeted mucosal vaccine

By 3 Comments

Cell Specific Vaccine By Suk Ho Lim, 25 January 2015 I first became involved with this disease when I received a letter from the parents of a young woman who requested chiropractic therapy for their daughter. Since that time I have treated about 30 patients suffering from this mysterious disease. The symptoms resemble those of […]

[Continue reading...]

Suspected side effects to the quadrivalent human papilloma vaccine, Gardasil

By 4 Comments

Quadrivalent human papilloma vaccine By Louise Brinth1, 2, Ann Cathrine Theibel1, 2, Kirsten Pors1, & Jesper Mehlsen1, 2 1) Coordinating Research Centre/Syncope Unit, Grederiksberg Hospital; 2) Department of Clinical Physiology and Nuclear Medicine, Frederiksberg Hospital, Denmark Abstract Introduction: The quadrivalent vaccine that protects against human papilloma virus types 6, 11, 16 and 18 (Q-HPV vaccine, Gardasil) […]

[Continue reading...]

What if HPV does NOT cause cervical cancer?

By 40 Comments

Sanevax square

Cervical Cancer? By Norma Erickson and Peter H. Duesberg, PhD The title of a paper recently published by McCormack et al in Molecular Cytogenetics says it all, ”Individual karyotypes at the origins of cervical carcinomas.” If the findings in this paper are true, a vaccine against human papillomavirus (HPV) is extremely unlikely to protect against […]

[Continue reading...]

The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.

By Leave a Comment

ASIA Syndrome Epidemiological Profile of ASIA Syndrome After HPV Vaccination Pellegrino P1, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, Radice S. Author information   Abstract The term “ASIA-Autoimmune/inflammatory Syndrome Induced by Adjuvants” describes an umbrella of clinical conditions sharing similar signs or symptoms, including post-vaccination phenomena. No information is available on the […]

[Continue reading...]

Making Vaccines with cancer cells: How safe is it?

By 16 Comments

Sanevax square

Cancer Cells By Sandy Lunoe, Guest Author Will vaccines produced using human cancer cells make vaccines more likely to cause cancer? Do the amounts of residual cancer DNA present in the vaccines vary between batches? What genetic mutations could occur should the residual cancer DNA enter a human cell and begin reproducing? Will manufacturers be […]

[Continue reading...]

Carmen de Bolivar: Neuropathic pain epidemic among Colombian girls

By 1 Comment

Neuropathic Pain Original Research By Pompilio Martinez N., M.D. Alumnus, School of Medicine, Universidad Nacional de Colombia. Former researcher Colombian National Institute of Health, Bogotá, Colombia Abstract The presence of neuropathic pain was investigated in 19 adolescents from Carmen de Bolívar (Colombia) and 2 women from the rest of the country with a history of immunization with […]

[Continue reading...]

Japan: Committed to HPV vaccine Safety, Efficacy and Need

By 7 Comments

Sanevax square

By Norma Erickson The International Symposium on the adverse reactions experienced by girls who have been vaccinated by Human Papillomavirus vaccines and subsequent events which took place in Tokyo this year on February 25th and 26th sparked a debate over HPV vaccine safety, efficacy and need. The Researchers’ Organization Sounding a Warning concerning the Adverse Reactions […]

[Continue reading...]

Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line

By Leave a Comment

Intracellular Aluminium Adjuvant Authors:  Matthew Mold, Håkan Eriksson, Peter Siesjö, Anna Darabi, Emma Shardlow & Christopher Exley Abstract Aluminium-based adjuvants (ABA) are the predominant adjuvants used in human vaccinations. While a consensus is yet to be reached on the aetiology of the biological activities of ABA several studies have identified shape, crystallinity and size as critical factors affecting their adjuvanticity. In […]

[Continue reading...]

Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination

By 2 Comments

Premature Ovarian Insufficiency: A Case Series Seen in General Practice Authors: Deirdre Therese Little, MBBS, DRANZCOG, FACRRM1, Harvey Rodrick Grenville Ward, Bsc(Med), MBChB, DMCOG, FCOG(SA), MMed (O&G), FRANZCOG2 Abstract Three young women who developed premature ovarian insufficiency following quadrivalent human papillomavirus (HPV) vaccination presented to a general practitioner in rural New South Wales, Australia. The unrelated girls […]

[Continue reading...]

Transmission of Vaccine-Derived Rotavirus (RotaTeq)

By Leave a Comment

Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis Rotavirus (RotaTeq) Authors: Daniel C. Payne, PhD, MSPHa, Kathryn M. Edwards, MDb, Michael D. Bowen, PhDc, Erin Keckley, RNb, Jody Peters, MSb, Mathew D. Esona, PhDc, Elizabeth N. Teel, BSc, Diane Kent, RNb, Umesh D. Parashar, MBBS, MPHa, Jon R. Gentsch, PhDc Abstract Although rotavirus vaccines are known to be shed in stools, transmission of […]

[Continue reading...]

Dr. Paul Offit: Busted!

By 6 Comments

By Lloyd Phillips, Guest Author Dr. Paul Offit uses the “laws of immunization” developed by Professor Melvin Cohn to prove that an infant can safely be vaccinated 10,000 or even 100,000 times, and that multiple vaccinations are perfectly safe. In Paul Offit’s paper: “Addressing Parents’ Concerns: Do Multiple Vaccines Overwhelm or Weaken the Infant’s Immune System?” Dr. […]

[Continue reading...]

Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

By Leave a Comment

Aluminum Adjuvant Toxicity Tomljenovic L1, Shaw CA. Abstract Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by […]

[Continue reading...]

France: Meeting to debate HPV vaccines, Gardasil and Cervarix

By 8 Comments

Sanevax square

By Norma Erickson Paris, 23 June 2014: A three hour discussion was held during which various medical professionals, politicians, and health authorities had the opportunity to openly debate serious concerns about the HPV vaccines Gardasil and Cervarix. Dr. Philippe de Chazournes recently sponsored an open letter to the French Minister of Health calling for the […]

[Continue reading...]

Gardasil: Cervical Cancer or Politicians Cancer?

By 1 Comment

Gardasil: Cervical Cancer or Politicians Cancer? ‘Gardasil: Cervical Cancer or Politicians Cancer?’ 09th June 2014 | by Philippe de Chazournes Your opinion, please, Madam Health Minister! We certainly live in ‘remarkable’ times!  These are times when one has to fight on a daily basis for common sense to prevail and for the stretching or bending […]

[Continue reading...]

News

Videos

Contact